Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on bipolarity and currently lists study information in Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, the Netherlands, Serbia and Montenegro, Spain, Sweden, Switzerland, and the United States.
In SwitzerlandThis study is completed. It focuses on schizophrenia and currently lists study information in Switzerland.
In Switzerland
This study has public registry information. It focuses on PTSD and currently lists study information in Switzerland.
In SwitzerlandThis study is completed. It focuses on ADHD and currently lists study information in Switzerland.
In SwitzerlandThis study has public registry information. It focuses on ADHD and currently lists study information in Switzerland.
In SwitzerlandThis study is completed in France, in Switzerland, in Germany, .... It is testing Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate for ADHD.
In SwitzerlandThis study is completed. It focuses on schizophrenia and currently lists study information in Switzerland.
In SwitzerlandThis study has public registry information. It focuses on schizophrenia and currently lists study information in Switzerland.
In SwitzerlandThis study is completed. It focuses on suicide prevention and currently lists study information in Switzerland.
In SwitzerlandThis study is completed. It focuses on PTSD and currently lists study information in Switzerland.
In SwitzerlandThis study is completed in Switzerland. It focuses on PTSD.
In Switzerland
This study has public registry information. It focuses on depression and currently lists study information in Switzerland.
In SwitzerlandHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.